Abstract:Several drugs of aziridinylbenzoquinone analogs have undergone clinical trials as potential antitumor drugs. These bioreductive compounds are designed to kill tumor cells preferentially within the hypoxic microenvironment. From our previous reported data, it was round that the synthesized 2-aziridin-1-yl-3-[(2-{2-[(3-aziridin-1,4-dioxo-1,4-dihydronaphthalen-2-yl)thio]ethoxy}ethyl)thio]naphthoquinone (AZ-1) is a bioreductive compound with potent lethal effect on oral cancer cell, OEC-M1. It was found in this study that the lethal effect of the oral cancer cell lines OEC-M1 induced by AZ-1 wits mediated through the cell cycle arrest and apoptosis pathway.The LC50 Values of OEC-M1 and KB cells induced by AZ-1 compound were 0.72 and 1.02 mu M, respectively, which were much lower than that of normal fibroblast cells (SF with LC50 = 5.6 mu M) with more than 90% of normal fibroblasts surviving as compared to control at a concentration of AZ-1 as high as 2 mu M. It was interesting to note that the LC50 of monotype diaziridinylbenzoquinone compound, diaziquone (AZQ), was 50 mu M on OEC-M1 cells. Comparing the cytotoxicity of AZ-1 and AZQ on OEC-M1 cells, AZ-1 is approximately 70 times more potent than AZQ.By using Western blot, both G(2)/M phase cell cycle arresting protein, cyclin B, and anti-apoptotic protein, bel-2, were expressed in OEC-M1 cell when the concentrations or AZ-1 were increased from 0.125 to 0.5 mu M and then decreased from 1o 2 mu M of AZ-1 treatment as compared with control for 24 h. Both proteins were expressed most abundantly at 0.5 mu M AZ-1. However, the expression of bel-2 protein in OEC-M1 was significantly decreasing in a dose-dependent manner and was only about 50% protein level at 2 mu M AZ-1 for 48 h as compared with control. The cell survival check protein p53 increased from 1.72- to 2.8-fold and 1.36- to 2.16 fold at concentrations of AZ-1 from 0.125 to 2.0 mu M in it dose-dependently increasing manner on OEG-M1 as compared with control For 24 and 48 h treatments, respectively. The apoptotic-related phenomena were observed, which included apoptotic body formation and the enzyme activity change of caspase-3. The apoptotic bodies and caspase-3 activity of OEC-M1 were induced only at 2 mu M AZ-1 for a 24 h treatment, yet apoptotic body formation was observed at as low as 0.5 mu M AZ-1 and in a dose-dependently increasing manner for a 48 h treatment. The caspasc-3 activity was increased 20%, 26.8%, and 84.2%,, respectively, at 0.5, 1, and 2 mu M concentrations of AZ-1 for a 48 h treatment as compared with control. These results indicate that AZ-1 induced the cell death of OEG-M1 through the G(2)/M phase arrest of cell cycle and anti-apoptosis first and then apoptosis following a 48 h treatment. All of the pathway might be associated with bel-2 and p53 protein expression. We propose that the AZ-1 could be used its anti-oral cancer drug for future studies with animal models. (c) 2005 Elsevier Ltd. All rights reserved.

The Lethal Effect of Bis-Type Azridinylnaphthoquinone Derivative on Oral Cancer Cells (OEC-M1) Associated with Anti-Apoptotic Protein Bcl-2.

[Selective Inducement Effect of Bacterial Redox Protein Azurin on Apoptosis of Human Osteosarcoma Cell Line U2OS].

Synthesis And Biological Evaluation Of 3-Aryl-Quinoxaline-2-Carbonitrile 1,4-Di-N-Oxide Derivatives As Hypoxic Selective Anti-Tumor Agents

A Benzimidazole-Based N-Heterocyclic Carbene Derivative Exhibits Potent Antiproliferative and Apoptotic Effects against Colorectal Cancer

Synthesis and Biological Evaluation of 3-Aryl-quinoxaline-2-carbonitrile 1,4-Di-<em>N</em>-oxide Derivatives as Hypoxic Selective Anti-tumor Agents

Cell Death Caused by Quinazolinone HMJ-38 Challenge in Oral Carcinoma CAL 27 Cells: Dissections of Endoplasmic Reticulum Stress, Mitochondrial Dysfunction and Tumor Xenografts.

Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer Therapy

A Prolyl-Hydroxylase Inhibitor, Ethyl-3,4-Dihydroxybenzoate, Induces Cell Autophagy and Apoptosis in Esophageal Squamous Cell Carcinoma Cells via Up-Regulation of BNIP3 and N-myc Downstream-Regulated Gene-1

Antiproliferation- and Apoptosis-Inducible Effects of a Novel Nitrated [6,6,6]Tricycle Derivative (SK2) on Oral Cancer Cells

[Apoptosis of Human Carcinoma of Mouth Floor KB Cells and Multidrug Resistant KBv200 Cells Induced by Azide Methyl Anthraquinone Derivative].

Experimental study of apoptosis of human breast cancer MDA-MB-231 cell line induced by AZD2281

Potential Use of Alexidine Dihydrochloride As an Apoptosis-Promoting Anticancer Agent

The Novel Benzothiazole Derivative PB11 Induces Apoptosis via the PI3K/AKT Signaling Pathway in Human Cancer Cell Lines

A Novel 7‐azaisoindigo Derivative‐induced Cancer Cell Apoptosis and Mitochondrial Dysfunction Mediated by Oxidative Stress

An NQO1 Substrate with Potent Antitumor Activity That Selectively Kills by PARP1-induced Programmed Necrosis.

Antitumor Effect of N-(4-Chlorophenyl)-5,6,7-Trimethoxyquinazolin-4-Amine Dihydrochloride on Tumor Cells in Vitro

G1 Phase Cell Cycle Arrest in NSCLC in Response to LZ-106, an Analog of Enoxacin, is Orchestrated Through ROS Overproduction in a P53-dependent Manner

A potential anticancer agent 1,2-di(quinazolin-4-yl)diselane induces apoptosis in non-small-cell lung cancer A549 cells

Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma Through Down-Regulation of COX-2 Mrna and PGE2.

Mtor Inhibitor AZD8055 Inhibits Proliferation and Induces Apoptosis in Laryngeal Carcinoma.

A Novel Andrographolide Derivative AL-1 Exerts Its Cytotoxicity on K562 Cells Through a ROS-dependent Mechanism.